Drug - Moderiba™ (ribavirin) [AbbVie Inc.]
Therapeutic area - Hepatitis C
Patients can not take metoclopramide oral tablets or oral solution.
Moderiba™ (ribavirin, USP) is a nucleoside analogue indicated for the treatment of chronic hepatitis C (CHC) virus infection in combination with peginterferon alfa-2a in adults with compensated liver disease not previously treated with interferon alpha, and in CHC patients coinfected with HIV.
MHCP Provider Call Center 651-431-2700 or 800-366-5411